Milliman Risk Score 2.0: stratifying mortality risk using prescription drug information


Our colleagues at Munich Re Life US assessed the effectiveness of the Milliman Rx Risk Score 2.0, a predictive modeling tool developed and owned by Milliman that assesses mortality risk using an individual’s prescription drug information. Our findings demonstrated that the enhanced Rx Risk Score 2.0 is indeed predictive of mortality for the U.S. insurance applicant population.


Contact the author
June Quah
June Quah
Vice President
Integrated Analytics
Munich Re North America Life